Of all of the aortic segments, the aortic arch is the last frontier for endovascular treatment. The main difficulty for arch repair is the lack of an appropriate proximal landing zone of at least 2 to ...
Endospan, a privately held, Israel-based company focused on the endovascular repair of aortic arch disease, announced 1-year ...
Clinical Trials Arena on MSN
Artivion’s aortic stents boost post-surgical outcomes in interventional studies
Two of the company’s aortic stents have displayed potential to improve patient outcomes post-surgery.
Endospan, a privately held company pioneering solutions for the endovascular repair of aortic arch disease, today announced the one-year results of their TRIOMPHE Investigational Device Exemption (IDE ...
Your aorta is a tube-like structure that resembles a candy cane. The thoracoabdominal aorta starts after the curve of the cane and extends past the arteries that deliver blood to the stomach, ...
A novel treatment developed by UCSF vascular surgeons has been used in a first-of-its-kind operation to repair a life-threatening aneurysm in the patient’s aortic arch, which carries blood from the ...
In order to find out what distinguishes the repeatedly affected vascular regions from others, Daniela Wenzel and her team from Bochum and Bonn, which is part of the Collaborative Research ...
Between the simpler approach of ascending aortic hemiarch replacement and a full-on extended arch reconstruction, overall ...
GlobalData on MSN
Endospan reports one-year TRIOMPHE study results for NEXUS system
The one-year data covers 94 high surgical risk patients across all arms.
A 56-year-old man with a medical history of hypertension, congestive heart failure, heavy smoking, alcoholism, and a small abdominal aortic aneurysm developed a 10 cm sacular aneurysm arising from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results